Advertisement
News
Advertisement

BSX wins FDA approval for wireless defibrillator

Thu, 10/04/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Boston Scientific Corp. (NYSE: BSX) announced it has won U.S. Food and Drug Administration approval for a defibrillator which is implanted just under the skin and does not require wires, called leads, that connect to the heart. Investors lifted the Natick, Mass. medical device company’s stock more than 2 percent on the news.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading